Urovant Sciences Ltd. UROV

Set alert

Price alert · UROV

All alert types
— — —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
531.75M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-3.09
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Feb 12, 2021
50-d avg
16.21
200-d avg
13.98
1y target
16.17

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for UROV has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 16.17
Target (low)
16.00
Target (mean)
16.17
Target (high)
16.25
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 3
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

UROV analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.00-1.680.0%3.93M0.0%0
Next quarter0.000.00 – 0.00-0.990.0%8.30M0.0%0
Current year0.000.00 – 0.000.000.0%3.93M0.0%0
Next year0.000.00 – 0.000.000.0%67.57M+1619.3%0

Upgrades and downgrades

The latest rating changes

UROV analyst upgrades and downgrades
DateFirmActionFromTo
Nov 16, 2020JP MorganDowngradeOverweightNeutral
Nov 16, 2020HC Wainwright & Co.DowngradeBuyNeutral
Nov 13, 2020JefferiesDowngradeBuyHold
Jun 19, 2020HC Wainwright & Co.Maintained—Buy
Dec 31, 2019H.C. WainwrightMaintained—Buy
Mar 15, 2019SunTrust Robinson HumphreyInitiated—Buy
Mar 11, 2019H.C. WainwrightInitiated—Buy
Oct 22, 2018JP MorganInitiated—Overweight
Oct 22, 2018JefferiesInitiated—Buy